122 related articles for article (PubMed ID: 16166837)
1. Bone scintigraphy in common tumors with osteolytic components.
Wang K; Allen L; Fung E; Chan CC; Chan JC; Griffith JF
Clin Nucl Med; 2005 Oct; 30(10):655-71. PubMed ID: 16166837
[TBL] [Abstract][Full Text] [Related]
2. Bone scintiscanning in osteolytic lesions.
Solav S
Clin Nucl Med; 2004 Jan; 29(1):12-20. PubMed ID: 14688592
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J
BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599
[TBL] [Abstract][Full Text] [Related]
4. Osteoblastic bone metastases in breast cancer: is not seeing believing?
Fogelman I
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1250-2. PubMed ID: 16133386
[No Abstract] [Full Text] [Related]
5. [Intraosseous osteolytic lesions. Diagnostic, differential diagnosis and therapy (author's transl)].
Adler CP; Wenz W
Radiologe; 1981 Oct; 21(10):470-9. PubMed ID: 6946521
[TBL] [Abstract][Full Text] [Related]
6. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123
[TBL] [Abstract][Full Text] [Related]
7. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
8. Unusual bilateral symmetrical osteolytic metastases visualized by bone scintigraphy.
Reddy MP; Floresca J; Juweid M; Graham MM
Clin Nucl Med; 2002 Apr; 27(4):299-301. PubMed ID: 11914676
[No Abstract] [Full Text] [Related]
9. Bone scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Morteímans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP99-106. PubMed ID: 14989222
[No Abstract] [Full Text] [Related]
10. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
Sahin E; Zincirkeser S; Akcan AB; Elboga U
J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
[TBL] [Abstract][Full Text] [Related]
11. Intense uptake of Tc-99m HMDP in pleural metastasis from osteosarcoma.
Biyi A; Doudouh A; Albouzidi A; Zekri A
Clin Nucl Med; 2006 Jul; 31(7):423-4. PubMed ID: 16785816
[No Abstract] [Full Text] [Related]
12. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Nakai T; Okuyama C; Kubota T; Yamada K; Ushijima Y; Taniike K; Suzuki T; Nishimura T
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1253-8. PubMed ID: 16133397
[TBL] [Abstract][Full Text] [Related]
13. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
14. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients.
McKillop JH; Etcubanas E; Goris ML
Cancer; 1981 Sep; 48(5):1133-8. PubMed ID: 6268278
[TBL] [Abstract][Full Text] [Related]
15. Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.
García JR; Simó M; Soler M; Pérez G; López S; Lomeña F
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1243-4. PubMed ID: 16133396
[No Abstract] [Full Text] [Related]
16. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors].
Okuyama T; Suzuki H; Nakamoto K; Suzuki S
Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357
[No Abstract] [Full Text] [Related]
17. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
Gedik GK; Ata O; Karabagli P; Sari O
Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of bone scintigraphy on diagnosis of malignant fibrous histiocytoma of bone].
Shimosegawa E; Yamasaki T; Shimizu M; Nakamura M; Sakamoto S
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Feb; 49(2):206-13. PubMed ID: 2547197
[TBL] [Abstract][Full Text] [Related]
20. Use of bone scintigraphy to select patients with multiple myeloma for treatment with strontium-89.
Edwards GK; Santoro J; Taylor A
J Nucl Med; 1994 Dec; 35(12):1992-3. PubMed ID: 7989983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
